
ESGO-ENYGO-ESO Masterclass in Gynaecological Oncology
20.06.2019 - 22.06.2019
Prague, Czech Republic
MASTERCLASS
Description
Scientific and Organising Committe: D. Querleu, FR - F. Peccatori, IT - K. Zalewski, PL - M.J. Halaska, CZ
After tree successful Masterclass editions, the Masterclass 2019, organized by ESGO, ENYGO (European Network of Young Gynaecological Oncologists) and ESO (European School of Oncology), will present up-to-date, standardised knowledge of the multidisciplinary management of gynaecological cancers to future gynaecological oncologists across Europe. The course furthers the organisations’ key goal of harmonising gynaecological oncology training and education throughout Europe.
COURSE HIGHLIGHTS
• Entire curriculum focused on gynae-oncological subspecialty theory
• State of the art lectures, video sessions, and interactive tumour boards
• Tracks on pelvic anatomy, diagnosis and treatment of cervical, vulvar, endometrial, and ovarian cancers
• Miscellaneous topics : perioperative and supportive care, fertility preservation, management of treatment complications, and palliative care
• Case reports presented by participants and interactively discussed at each track
• International faculty
TEACHING FORMAT
The Masterclass is a 3-day residential educational event covering key topics of the curricula needed for the ESGO accreditation in the subspecialty of gynaecological oncology.
This year, following previous participants’ feedback, discussion and tumour board time will be extended.
In addition, to make this year's event even more interactive, selected participants will have a unique opportunity to present and discuss their case study in 4 workshops. View the Call for Case studies Abstracts below.
After the Masterclass, participants will have a full picture of the basics of different gynaecological cancers, their treatment, and care in compliance with the ESGO-defined standards of training in gynaecological oncology.
An international faculty of leading experts in the field will contribute to the program. Participation is compulsory throughout the course. The Masterclass will be conducted entirely in English.
Held in cooperation with |
|||||||
![]() |
![]() |
General information
ORGANISING SECRETARIAT
ESGO Office
Palace YMCA, Na Porici 12/1041
110 00 Prague 1
Czech Republic
Email: masterclass2019@esgomail.org
Event website: www.esgo.org/masterclass-2019
GENERAL INFORMATION
The ideal Masterclass candidate is a trainee or fellow in gynaecological oncology who holds ENYGO membership and speaks fluent English.
The Masterclass will be held at the auditorium of the Medical University of Warsaw, Poland.
Course attendance is limited to 80 participants; registrations will be treated on a first-come-first-served basis. Priority will be given to people who have not yet participated in a Masterclass. The official course language is English.
Accommodation
TRAVEL
Attendees are responsible for their own travel arrangements.
ACCOMMODATION
Hotel:
Vienna House Diplomat Prague, Evropská 370/15, 160 41 Prague, Czech Republic
Accommodation for 2 nights in a double room, in a standard hotel in the vicinity of the course venue will be arranged and covered by ESGO from Thursday, June 20 (check in) until Saturday, June 22, 2019 (check out).
In case that you need an extra night (paid directly by yourself) on the day before/after the workshop, we can arrange that directly with the hotel. In such a case be so kind and inform us in due time.
Programme
20 June
11:00 | Registration |
|
12:00 | Welcome coffee and snacks | |
13:00 | Welcome ESGO/ENYGO/ESO |
|
PELVIC ANATOMY applied to gynaecological cancer surgery |
||
13:15 | Surgical spaces, lymphatic drainage, nerves, topography |
|
13:35 | Histopathology and immunohistochemistry | |
13:55 | Principles of radiotherapy |
|
CERVICAL CANCER I |
||
14:20 | Ultrasound, MRI in cervical cancer | |
14:40 | Management of early invasive carcinoma (Stage IA1, IA2, IB1, IIA1) | |
15:00 | Management of locally advanced cervical carcinoma (IB2, >IIA2) | |
15:20 | Management of primary metastatic, persistent and recurrent Cx ca. | |
15:40 | Coffee break | |
CERVICAL CANCER II |
||
16:10 | Video of laparoscopic pelvic lymphadenectomy |
|
16:25 | Video of radical hysterectomy (including nerve sparing) |
|
16:40 | Fertility sparing procedures in cervical carcinoma (trachelectomy, NAC) |
|
17:00 | Tumor board 1: Presentation of selected clinical cases by participants with discussion |
|
18:00 | Discussion |
|
18:20 | End of the day |
21 June
VULVAR CANCER |
||
9:00 | Primary treatment of early stage vulvar cancer |
|
9:25 | Management of advanced stage and recurrent vulvar cancer |
|
9:45 | Video: Partial/Radical vulvectomy and groin node dissection, SLNM |
|
9:55 | Tumor board 2: Vulvar cancer cases |
|
10:30 | Discussion |
|
11:00 | Coffee break |
|
MALIGNANT TUMOURS OF THE UTERUS I |
||
11:20 | Diagnosis in endometrial cancer |
|
11:40 | Surgical management of endometrial cancer |
|
12:10 | Adjuvant treatment of endometrial cancer and recurrent disease |
|
MALIGNANT TUMOURS OF THE UTERUS II |
||
13:40 | Video: Open paraaortic lymphadenectomy |
|
13:50 | Video: Laparoscopic paraaortic lymphadenectomy (trans, retroperit.) |
|
14:05 | Fertility preserving options in endometrial cancer |
|
MISCELLANEOUS 1 |
||
14:20 | Breast cancer | |
14:55 | Diagnosis and management of uterine sarcoma | |
15:10 | Familial Gynaecological Cancer - risk assessment and management | |
16:00 | Perioperative care | |
16:20 | Tumor board 2: Presentation of selected clinical cases by participants with discussion | |
17:30 | End of the day | |
19:30 | Networking event |
22 June
MISCELLANEOUS 2 |
||
9:00 | Symptom control and pain management (palliative care) |
|
9:20 | Management of surgical complications |
|
9:50 | Supportive care and management of side effects of systemic therapy |
|
MALIGNANT TUMOURS OF THE OVARIES |
||
10:20 | Diagnosis and staging of ovarian cancer | |
10:40 | Surgical management of primary and recurrent ovarian cancer | |
11:40 | Adjuvant treatment in early, advanced and recurrent ovarian cancer | |
12:10 | Video: surgical procedures in advanced ovarian cancer | |
13:25 | Management of non-epithelial ovarian malignancies | |
13:45 | Tumor board 3: Presentation of selected clinical cases by participants with discussion | |
14:45 | Discussion | |
15:00 | Closing remarks Good bye lunch bags |
Follow us